SR-202: Selective PPARγ Antagonist for Immunometabolic Re...
2025-10-17
SR-202 redefines metabolic and immunological research with precise, selective PPARγ antagonism, enabling advanced dissection of adipocyte differentiation and macrophage polarization. Its unique properties accelerate anti-obesity, insulin resistance, and type 2 diabetes studies by offering robust, reproducible inhibition of the PPAR signaling pathway.